Metabolic control with insulin pump therapy: Preliminary experience

Journal of the Chinese Medical Association

Volumn 71, Issue 7, 2008, Pages 353-356

  Hsu, Shang Ren ^a   Lin, Shi Dou ^a   Tu, Shih Te ^a   Liao, Pei Yung ^a   Su, Shih Li ^a   Lin, Su Lan ^a   Tseng, Ya Yu ^a   Huang, Pei Wen ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Continuous subcutaneous insulin infusion (CSII); Diabetic ketoacidosis; Glycosylated hemoglobin A (HbA1C)

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ANALYSIS OF VARIANCE; APPLICATION SITE INFECTION; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

EID: 50049130478     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70138-2     Document Type: Article

References (26)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998;352:837-53.
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
4. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25:593-8.
5. Nielsen S, Kain D, Szudzik E, Dhindsa S, Garg R, Dandona P. Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus. Diabetes Educ 2005;31:843-8.
6. Wainstein J, Metzger M, Boaz M, Minuchin O, Cohen Y, Yaffe A, Yerushalmy Y, et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 2005;22:1037-46.
7. Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century: strategies for successful usc in adults, adolescents, and children with diabetes. Postgrad Med 2002;111:69-77.
8. Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002;18(Suppl 1): S14-20.
9. Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:1142-6.
10. Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, Tamborlane WV. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1C levels across all age groups. Pediatric Diabetes 2002;3:10-5.
11. Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP. Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 2007;9:421-8.
12. Reda E, Von Reitzenstein A, Dunn P. Metabolic control with insulin pump therapy: the Waikato experience. N Z Med J 2007; 120:2401-12.
13. Rizvi AA, Petry R, Arnold MB, Chakraborty M. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Endocr Pract 2001;7:364-9.
14. Kamoi K. Good long-term quality of life without diabetic complications with 20 years of continuous subcutaneous insulin infusion therapy in a brittle diabetic elderly patient. Diabetes Care 2002;25:402-4.
15. American Association of Diabetes Educators. Education for continuous subcutaneous infusion pump users. Diabetes Educ 2003;29:97-9.
16. American Diabetes Association. Continuous subcutaneous insulin infusion. Diabetes Care 2004;27(Suppl 1):S110.
17. Lavin-Tompkins J. Insulin pump therapy: situations and solutions. Lippincotts Prim Care Pract 1997;1:519-26.
18. de Weerdt I, Visser AP, Kok G, van der Veen EA. Determinants of active self-care behaviour of insulin treated patients with diabetes: implications for diabetes education. Soc Sci Med 1999; 30:605-15.
19. Bott U, Jorgens V, Grusser M, Bender R, Mühlhauser I, Berger M. Predictors of glycemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 1994;11:362-71.
20. Kitabchi AE, Fisher JN, Burghen GA, Gaylord MS, Blank NM. Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes. Diabetes Care 1979;2:421-4.
21. Levy-Marchal C, Czernichow P. Feasibility of continuous subcutaneous insulin infusion in young diabetic patients. Diabete Metab 1988;14:108-13.
22. Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 1995;27:199-204.
23. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-84.
24. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes 2006;7(Suppl 4):32-8.
25. Gabbe SG, Holing E, Temple P, Brown Z. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000;182:1283-91.
26. Giménez M, Conget I, Nicolau J, Pericot A, Levy I. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy: a case-control study. Acta Diabetol 2007;44:34-7.